Company / Accounts Receivable
Medtronic Accounts Receivable History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$6.5B
FY2025
5-year range
$5.6B / $6.5B
FY2021-FY2025
Trend
+6.3%
vs FY2024
Sector context
#7 of 138
Health Care
What the data says
Among 138 Health Care companies, Medtronic is in the top 5% for accounts receivable. Accounts Receivable has increased for 5 consecutive years, from $4.6B in FY2020 to $6.5B in FY2025.
Based on SEC 10-K filings.
$6.5B in FY2025 with a 5-year CAGR of +7.0%. Top quartile in the Health Care sector.
Improved from $6.0B to $6.5B over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +5.5%
- 5-Year CAGR
- +7.0%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 138This company $6.5B Sector average $1.3B
▼
+393.3% above sector average
Key checks
Key Insights
- Medtronic's accounts receivable has grown for 5 consecutive years.
- 5-year CAGR of +7.0%, indicating consistent growth.
- In FY2025, accounts receivable increased 6.3% year-over-year.
- Ranks #7 out of 138 companies in the Health Care sector.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | $6.5B | +6.3% |
| FY2024 | $6.1B | +2.2% |
| FY2023 | $6.0B | +8.1% |
| FY2022 | $5.6B | +1.6% |
| FY2021 | $5.5B | +17.6% |
| FY2020 | $4.6B | -25.3% |
| FY2019 | $6.2B | +3.9% |
| FY2018 | $6.0B | +7.1% |
| FY2017 | $5.6B | +0.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026